Pratik Choudhary is Professor and Honorary Consultant in Diabetes with a special interest in type 1 diabetes and technology at the University of Leicester, and Honorary Consultant at the University Hospitals of Leicester NHS Trust.

After finishing his medical training in India, he completed an MD thesis on the use of continuous glucose monitoring in the study of hypoglycaemia from Sheffield, before moving to King’s College London. There, he was clinical lead for type 1 diabetes as well as the islet and pancreas transplant programme.

Professor Choudhary has active clinical and research programs around education, psychology and technology in type 1 diabetes. In particular, his research uses neuroimaging to explore the mechanisms of hypoglycaemia unawareness, and the use of different strategies, such as technology and behavioral interventions, to restore awareness. He is work-package lead for the Hypo-RESOLVE consortium, within which he is principal investigator of Hypo-METRICS, a large multinational study evaluating the biological and psychosocial impacts of sensor-detected hypoglycaemia. He has been involved in a number of national and international research studies, as well as a number of national and international training and education programs for diabetes. He has published over 150 papers in peer-reviewed journals as well as over 10 book chapters.

He is currently chair of the Diabetes Technology Network-UK, working to improve access to technology for diabetes through training, education and advocacy.  He is also a member of the EASD postgraduate education committee and the medical advisory panel on diabetes to the department of transport in the UK as well as an associate editor for Diabetic Medicine.

Duality of Interest: : Professor Choudhary has received research support / grants from Abbott, Medtronic and Novo Nordisk, and speaker’s honorarium / fees from Abbott, AstraZeneca, Dexcom, Glooko, Insulet, Lilly, Medtronic, Novo Nordisk, and Sanofi. He has also received payments for membership of boards/advisory panels from Abbott, Dexcom, Lilly, Medtronic and Sanofi.

Date: Winter 2022